NCT05184621View on ClinicalTrials.gov

The Effectiveness and Safety of Low-intensity Single-wavelength Red Light in Controlling High Myopia in Children and Adolescents：A Randomized, Controlled, Multicenter Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

February 4, 2021

Primary Completion Date

April 15, 2023

Study Completion Date

April 15, 2023

Conditions
Age 3 to 16 Years (Inclusive), Male or FemaleClinical Diagnosis Confirming That Myopia Has Occurred in at Least One EyeThe Guardian Voluntarily Signed the Subject's Informed Consent Form
Interventions
OTHER

Eyesing Redlight Instrument

Eyesing Instrument developed by Suzhou Industrial Park Zoguan Medical Equipment Co. and conventional optometry.

Trial Locations (1)

200040

Shanghai Eye Disease Prevention & Treatment Center, Shanghai

All Listed Sponsors
collaborator

Zuoguan Medical Equipment Co., Ltd. at Suzhou Industrial Park

UNKNOWN

collaborator

Children's Hospital of Soochow University

OTHER

collaborator

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

collaborator

Shanghai East Hospital

OTHER

collaborator

The Children's Hospital of Zhejiang University School of Medicine

OTHER

collaborator

Shanxi Eye Hospital

OTHER

lead

Shanghai Eye Disease Prevention and Treatment Center

OTHER

NCT05184621 - The Effectiveness and Safety of Low-intensity Single-wavelength Red Light in Controlling High Myopia in Children and Adolescents：A Randomized, Controlled, Multicenter Clinical Trial | Biotech Hunter | Biotech Hunter